mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |